Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.42
+0.09 (0.96%)
Nov 21, 2024, 4:00 PM EST - Market closed
Immunome Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$28.60
Upside
+203.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +122.93% | Nov 14, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $30 | Buy | Initiates | $30 | +218.47% | Nov 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +250.32% | Oct 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $27 → $23 | Buy | Maintains | $27 → $23 | +144.16% | Aug 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $33 | Buy | Reiterates | $33 | +250.32% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $27 | Buy | Initiates | $27 | +186.62% | May 31, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $24 | Buy | Initiates | $24 | +154.78% | Apr 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +271.55% | Apr 15, 2024 |
| Wedbush | Wedbush | Buy Maintains $27 → $33 | Buy | Maintains | $27 → $33 | +250.32% | Apr 1, 2024 |
| Wedbush | Wedbush | Buy Maintains $12 → $19 | Buy | Maintains | $12 → $19 | +101.70% | Jan 23, 2024 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +27.39% | Dec 19, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | -15.07% | Mar 20, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | -15.07% | Mar 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $35 | Buy | Initiates | $35 | +271.55% | Oct 29, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +91.08% | Oct 27, 2020 |